Related Experiment Video
Updated: Jul 2, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral
Alicia C Wells1, Shahrdad Lotfipour1,2
1School of Medicine, University of California, Irvine, Irvine, CA, United States.
Insights
Maternal nicotine exposure during pregnancy, from smoking or e-cigarettes, increases risks for miscarriage, SIDS, and neurodevelopmental disorders like ADHD. This review examines prenatal nicotine exposure
Area of Science:
- Neuroscience
- Developmental Biology
- Public Health
Background:
- Maternal tobacco and e-cigarette use expose fetuses to nicotine, increasing risks for miscarriage, prematurity, low birth weight, and Sudden Infant Death Syndrome (SIDS).
- Prenatal nicotine exposure (PNE) is linked to neurodevelopmental issues, including Attention-Deficit Hyperactivity Disorder (ADHD), anxiety, depression, and altered brain circuitry in infants.
- High percentages of pregnant women in the U.S. and globally use nicotine products, necessitating a comprehensive review of PNE's effects.
Purpose of the Study:
- To synthesize pre-clinical and clinical research on neurobehavioral and neurodevelopmental complications from prenatal nicotine exposure (PNE).
- To investigate PNE's impact on the hypothalamic-pituitary-adrenal (HPA) axis and specific brain regions (PFC, VTA, NA, hippocampus, caudate).
- To discuss PNE's association with altered nAChR signaling, long-term drug-seeking behavior, and developmental disorders like ADHD, ASD, schizophrenia, anxiety, and obesity.
Main Methods:
- Systematic review and synthesis of existing pre-clinical and clinical studies.
- Analysis of research focusing on neurodevelopmental outcomes and brain alterations.
- Examination of epidemiological data on maternal nicotine product usage during pregnancy.
Main Results:
- PNE is associated with significant alterations in fetal neurodevelopment, impacting brain structure and function.
- Nicotine exposure affects key neurotransmitter systems and receptor signaling, including cholinergic pathways.
- Evidence suggests a correlation between PNE and increased risk for various neurodevelopmental and psychiatric disorders in offspring.
Conclusions:
- Prenatal nicotine exposure poses substantial risks to infant neurodevelopment and long-term behavioral outcomes.
- Understanding these risks is crucial for public health initiatives aimed at reducing maternal nicotine use.
- Further research is warranted to elucidate the precise mechanisms and long-term consequences of PNE.
Abstract:
Maternal tobacco use and nicotine exposure during pregnancy have been associated with adverse birth outcomes in infants and can lead to preventable pregnancy complications. Exposure to nicotine and other compounds in tobacco and electronic cigarettes (e-cigarettes) has been shown to increases the risk of miscarriage, prematurity, stillbirth, low birth weight, perinatal morbidity, and sudden infant death syndrome (SIDS). Additionally, recent data provided by clinical and pre-clinical research demonstrates that nicotine exposure during pregnancy may heighten the risk for adverse neurodevelopmental disorders such as Attention-Deficit Hyperactivity (ADHD), anxiety, and depression along with altering the infants underlying brain circuitry, response to neurotransmitters, and brain volume. In the United States, one in 14 women (7.2%) reported to have smoked cigarettes during their pregnancy with the global prevalence of smoking during pregnancy estimated to be 1.7%. Approximately 1.1% of women in the United States also reported to have used e-cigarettes during the last 3 months of pregnancy. Due to the large percentage of women utilizing nicotine products during pregnancy in the United States and globally, this review seeks to centralize pre-clinical and clinical studies focused on the neurobehavioral and neurodevelopmental complications associated with prenatal nicotine exposure (PNE) such as alterations to the hypothalamic-pituitary-adrenal (HPA) axis and brain regions such as the prefrontal cortex (PFC), ventral tegmental area (VTA), nucleus accumbens (NA), hippocampus, and caudate as well as changes to nAChR and cholinergic receptor signaling, long-term drug seeking behavior following PNE, and other related developmental disorders. Current literature analyzing the association between PNE and the risk for offspring developing schizophrenia, attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), anxiety, and obesity will also be discussed.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
CNS Depressants: Alcohol and Nicotine
Teratogenicity

